Economic Evaluation Plan of a Randomised Controlled Trial of Intra-Nodular Injection of Anti-TNF and Placebo Among Patients With Early Dupuytren’s Disease: Repurposing Anti-TNF for Treating Dupuytren’s Disease (RIDD)
Wellcome Open Research - United Kingdom
doi 10.12688/wellcomeopenres.14936.2
Full Text
Open PDFAbstract
Available in full text
Date
February 12, 2019
Authors
Publisher
F1000 Research Ltd